Resistance to activated protein C as a basis for venous thrombosis.
about
The relationship of the factor V Leiden mutation or the deletion-deletion polymorphism of the angiotensin converting enzyme to postoperative thromboembolic events following total joint arthroplastyThrombophilia and pregnancyThe discovery of activated protein C resistanceExogenous estrogen may exacerbate thrombophilia, impair bone healing and contribute to development of chronic facial painAmerican College of Medical Genetics consensus statement on factor V Leiden mutation testingProthrombotic phenotype of protein Z deficiencyLow dose aspirin as prophylaxis against renal-vein thrombosis in renal-transplant recipientsHeteropolymeric triplex-based genomic assay to detect pathogens or single-nucleotide polymorphisms in human genomic samplesHeparin-induced thrombocytopenia and fatal thrombosis in a patient with activated protein C resistance.Activated protein C resistance caused by factor V Arg 506-->Gln mutation has no role in thrombotic manifestations of Behçet's disease.Predisposition to thrombosis by a factor V mutation causing hereditary resistance to activated protein C.Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosisThe investigation and management of inherited thrombophilia.Population differences in the frequency of the factor V Leiden variant among people with clinically symptomatic protein C deficiency.Cerebral venous sinus thrombosis associated with factor V gene mutation.Increased resistance to activated protein C and factor V Leiden in recurrent abortions. Review of other hypercoagulability factors.The effect of factor V Leiden carriage on maternal and fetal healthFactor V Leiden mutation and thromboembolism risk in women receiving adjuvant tamoxifen for breast cancerPhysiological anticoagulation. Resistance to activated protein C and venous thromboembolismOn the role of phosphatidylethanolamine in the inhibition of activated protein C activity by antiphospholipid antibodiesProtein S as an in vivo cofactor to activated protein C in prevention of microarterial thrombosis in rabbits.Hematologic genetic testing in high-risk patients before knee arthroplasty: a pilot study.Behçet's disease and thrombophilia.Prevalence of the factor V-Leiden mutation in four distinct American ethnic populations.Update on selected inherited venous thrombotic disorders.Prevalence of factor V Leiden in a Canadian blood donor populationLaboratory thrombophilias and venous thromboembolism.Arterial embolism to the upper extremity in a patient with factor V Leiden mutation (APC resistance)--a case report and review of the literature.Activated protein C resistance in patients with central retinal vein occlusion.Prevalence of factor V Leiden (APCR) and other inherited thrombophilias in young patients with myocardial infarction and normal coronary arteries.Combination of Surgical Thrombectomy and Direct Thrombolysis in Acute Abdomen with Portal and Superior Mesenteric Vein ThrombosisIdentification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein CHaemophilia and thrombophilia: an unexpected association!Resistance to activated protein C and digital thrombosis.The role of hypercoagulability in the development of osteonecrosis of the femoral head.Factor V Leiden is associated with higher risk of deep venous thrombosis of large blood vesselsThe presence of multiple prothrombotic risk factors is associated with a higher risk of thrombosis in individuals with anticardiolipin antibodies.The prothrombotic phenotypes in familial protein C deficiency are differentiated by computational modeling of thrombin generation.Identifying novel genetic determinants of hemostatic balance.Binding sites for blood coagulation factor Xa and protein S involving residues 493-506 in factor Va.
P2860
Q24799211-FF560ED5-9767-4253-B3D4-9F2965784B98Q24801115-2E9A372D-71B6-4454-B810-5DE054DF278AQ28188238-A174C84B-7122-4388-AA4F-DB152BD8B3A3Q28291444-41375796-7A69-4CF6-85AE-410C0BFFF6A5Q28361651-9DB5A149-BB1F-407A-9775-D380204E4E3BQ28509678-74B1D236-8860-4B64-965D-88EF04017364Q29999663-E2F3A06B-5FFA-4B0F-838A-9AF143F99D26Q33279525-44ADAF7E-C23A-4556-9C98-37C73F91700FQ33487557-BA3326C5-EA0B-464E-8D96-F8FAD625F872Q33578469-11F51634-7535-408C-B2F6-5FF08940D57AQ33608601-8726B723-8061-4D34-91D6-15D8322695CCQ33618227-33C1D54B-0D17-4E32-86A1-075FD6A7B492Q33643586-D5EA1EBA-B8A4-473A-B97D-77670C263587Q33677102-714E6827-66E3-4F00-84F5-3F8C24353757Q33735500-98F4E3F2-C84E-495F-B475-30F3A063FAB2Q33780732-8D1FA88F-D486-4AE8-AE81-2670CB921AA3Q33878487-E7641E59-40BD-41CD-A150-0DBF4C674411Q33965106-72E04EAE-C6E7-4BA1-937D-6103CF8296C2Q34181688-689471EB-AA42-469C-BC5C-C3E216D346B3Q34195707-2FC04E0D-410B-46EB-B11E-2F73CC44B7D4Q34214354-8ADBB427-7664-411F-9646-B023C50F4F77Q34434855-235BA159-E475-47D7-A461-D7996012F533Q34439906-ABA1BEDF-573B-4800-A63A-4396C2924A42Q34450894-5E31AE7C-024B-42FA-852A-7160EB5E88A0Q34469151-6C705D62-4864-487A-BA5B-5227B3965B0BQ34712722-EEE96877-F248-4239-B7F2-7061F15978C8Q34981644-24992059-2EA8-4AB6-8A84-9E6ABEF3B81AQ35068776-5231A548-9074-46C0-8028-C779ACD3B1F1Q35298277-BB55479C-09EB-4712-9C4E-30C2868D8D6DQ35369291-F957EF65-C644-47D4-A438-BB556AF90F68Q35779959-25F6E7B2-CD56-473A-A9DB-F681BDBB8BEDQ35824755-DAB15548-D787-4700-B99C-BA301C360BE8Q35824844-D847B6FA-7F4B-4165-8F89-16AEC630C263Q35836358-8B43C034-CB6B-420D-B029-5534D59FB9DAQ36092684-42AFD650-B0C0-4660-8CDD-E0E4B6467B2FQ36147640-258B97FF-7974-4913-A6F4-865C91F0E044Q36229639-F7B38E9E-DC35-4284-B9C6-A6678C68D980Q36229803-611B5DE2-676A-4BC3-9187-332456DA14BAQ36230809-CF6F9DC2-FF26-4296-AC84-254E3E52A9C0Q36280112-2D82530E-B5E2-4AC6-977E-544A8912B46B
P2860
Resistance to activated protein C as a basis for venous thrombosis.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Resistance to activated protein C as a basis for venous thrombosis.
@en
Resistance to activated protein C as a basis for venous thrombosis.
@nl
type
label
Resistance to activated protein C as a basis for venous thrombosis.
@en
Resistance to activated protein C as a basis for venous thrombosis.
@nl
prefLabel
Resistance to activated protein C as a basis for venous thrombosis.
@en
Resistance to activated protein C as a basis for venous thrombosis.
@nl
P1476
Resistance to activated protein C as a basis for venous thrombosis.
@en
P2093
Dahlbäck B
Svensson PJ
P304
P356
10.1056/NEJM199402243300801
P407
P577
1994-02-01T00:00:00Z